Nigeria's health tech sector, which was recently in the spotlight due to the COVID-19 pandemic, is now facing a challenging period. We examine the key factors affecting sector development and prospects for revival.
Pandemic as a Catalyst and Subsequent Decline
During the COVID-19 pandemic, Nigeria's health tech sector experienced rapid growth driven by the need for urgent medical solutions like telemedicine and vaccine distribution platforms. Startups like 54Gene and Helium Health attracted significant funding. However, as the pandemic subsided, the focus on health tech diminished, leading to a downturn, particularly marked by the shutdown of 54Gene, which raised $45 million.
Market Readiness and Barriers
The Nigerian market holds potential for digital healthcare solutions due to increasing smartphone and internet penetration. However, barriers such as high out-of-pocket healthcare spending make premium health tech services less accessible despite market readiness.
Financial and Structural Challenges
Funding for health tech in Nigeria continues to decline, linked to longer return-on-investment cycles compared to sectors like fintech, and the complexity of implementing technology. Challenges include poor infrastructure and a lack of successful local precedents.
Structural reforms and innovation are essential for Nigeria's health tech sector to become a leader in sustainable healthcare solutions not only in Nigeria but across the continent.
